The reduced form of coenzyme Q10 decreases the expression of lipopolysaccharide-sensitive genes in human THP-1 cells

Journal of Medicinal Food

Volumn 14, Issue 4, 2011, Pages 391-397

  Schmelzer, Constance ^a   Kohl, Christine ^a   Rimbach, Gerald ^a   Döring, Frank ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

coenzyme Q10, reduced form; gene expression; lipopolysaccharide regulation; microarray analysis; THP 1 monocytes

Indexed keywords

ADRENOMEDULLIN; B7 ANTIGEN; CCL4L2 CHEMOKINE; CENTAURIN; CRIM1 PROTEIN; EBI3 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; HERMES ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 7 RECEPTOR; KYNURENINASE; LIPOPOLYSACCHARIDE; MAML2 PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MONOCYTE CHEMOTACTIC PROTEIN 2; NUCLEAR RECEPTOR COACTIVATOR 2; PHOSPHOPROTEIN PHOSPHATASE 2; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLECKSTRIN; RAS GUANYL RELEASING PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RNF144B PROTEIN; SEC7 DOMAIN CONTAINING 3; SLAMF7 PROTEIN; SLC41A2 PROTEIN; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA INDUCED PROTEIN 6; UNCLASSIFIED DRUG; UNINDEXED DRUG; VISININ;

ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE IDENTIFICATION; GENE INDUCTION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MONOCYTE; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL LINE; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LIPOPOLYSACCHARIDES; MONOCYTES; NUCLEAR RECEPTOR COACTIVATOR 2; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; UBIQUINONE;

NEGIBACTERIA;

EID: 79953189728     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2010.0080     Document Type: Article

References (26)

1. Crane FL, Navas P: The diversity of coenzyme Q function. Mol Aspects Med 1997;18(Suppl):S1-S6.
2. Turunen M, Olsson J, Dallner G: Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004;1660:171-199. (Pubitemid 38125244)
3. Jones ME: Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Annu Rev Biochem 1980;49:253-279.
4. Echtay KS, Winkler E, Klingenberg M: Coenzyme Q is an obligatory cofactor for uncoupling protein function. Nature 2000;408:609-613.
5. Takayanagi R, Takeshige K, Minakami S: NADH- and NADPHdependent lipid peroxidation in bovine heart submitochondrial particles. Dependence on the rate of electron flow in the respiratory chain and an antioxidant role of ubiquinol. Biochem J 1980;192:853-860.
6. Ernster L, Dallner G: Biochemical, physiological and medical aspects of ubiquinone function. Biochim Biophys Acta 1995; 1271:195-204.
7. Romagnoli A, Oradei A, Destito C, Iacocagni A, Marin AW, Littarru GP: Protective role in vivo of coenzyme Q10 during reperfusion of ischemic limbs. Mol Aspects Med 1994;15(Suppl): s177-s185.
8. Alleva R, Tomasetti M, Battino M, Curatola G, Littarru GP, Folkers K: The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions. Proc Natl Acad Sci U S A 1995;92:9388-9391.
9. Schmelzer C, Lorenz G, Rimbach G, Doring F: In vitro effects of the reduced form of coenzyme Q10 on secretion levels of TNFalpha and chemokines in response to LPS in the human monocytic cell line THP-1. J Clin Biochem Nutr 2009;44:62-66.
10. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94. (Pubitemid 32222977)
11. Jovinge S, Ares MP, Kallin B, Nilsson J: Human monocytes= macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 1996;16:1573-1579. (Pubitemid 26427613)
12. Dominguez PM, Ardavin C: Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 2010;234:90-104.
13. Chute JP, Ross JR, McDonnell DP: Minireview: nuclear receptors, hematopoiesis, and stem cells. Mol Endocrinol 2010;24: 1-10.
14. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA: Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 1993;187:233-256. (Pubitemid 23150770)
15. Baeuerle PA, Baltimore D: NF-kappa B: ten years after. Cell 1996;87:13-20.
16. Scherf M, Epple A, Werner T: The next generation of literature analysis: integration of genomic analysis into text mining. Brief Bioinform 2005;6:287-297. (Pubitemid 41614550)
17. Dennis G Jr, Sherman BT, Hosack DA, et al.: DAVID: Database for Annotation, Visualization, and IntegratedDiscovery. Genome Biol 2003;4(5):P3.
18. Schmelzer C, Lorenz G, Lindner I, et al.: Effects of Coenzyme Q10 on TNF-alpha secretion in human and murine monocytic cell lines. Biofactors 2007;31:35-41. (Pubitemid 352032104)
19. Williams MR, Sakurai Y, Zughaier SM, Eskin SG, McIntire LV: Transmigration across activated endothelium induces transcriptional changes, inhibits apoptosis, and decreases antimicrobial protein expression in human monocytes. J Leukoc Biol 2009;86: 1331-1343.
20. Schmelzer C, Lorenz G, Rimbach G, Doring F: Influence of Coenzyme Q10 on release of pro-inflammatory chemokines in the human monocytic cell line THP-1. Biofactors 2007;31:211-217. (Pubitemid 352789889)
21. Navas P, Villalba JM, de Cabo R: The importance of plasma membrane coenzyme Q in aging and stress responses. Mitochondrion 2007;7(Suppl):S34-S40. (Pubitemid 46722290)
22. Vasiliou V, Ross D, Nebert DW: Update of the NAD(P)H: quinone oxidoreductase (NQO) gene family. Hum Genomics 2006;2:329-335.
23. Cauwels A, Rogge E, Janssen B, Brouckaert P: Reactive oxygen species and small-conductance calcium-dependent potassium channels are key mediators of inflammation-induced hypotension and shock. J Mol Med 2010;88:921-930.
24. Sanlioglu S, Williams CM, Samavati L, et al.: Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem 2001;276:30188-30198.
25. Schmelzer C, Kitano M, Rimbach G, et al.: Effects of ubiquinol- 10 on microRNA-146a expression in vitro and in vivo. Mediators Inflamm 2009;2009:415-437.
26. Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M: Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol 2007;47:19-28. (Pubitemid 44765121)